Literature DB >> 33630184

Exercise in Treatment of Migraine Including Chronic Migraine.

Tae-Jin Song1, Min Kyung Chu2.   

Abstract

PURPOSE OF REVIEW: With this review, we aimed to investigate the effect of exercise on migraine and explored the possibility of exercise as a treatment option for migraine. RECENT
FINDINGS: A close association of physical activity and exercise with migraine has been reported in clinical and population-based studies. Recent randomized controlled trials investigating the effect of aerobic exercise as a migraine-preventive treatment have revealed a notable improvement in migraine symptoms. Data on the effect of anaerobic exercise and exercise for flexibility, coordination, and relaxation on migraine are currently insufficient to make any recommendations. Possible pathways for the attenuation of migraine by exercise include the endogenous opioid and cannabinoid systems, brain-derived neurotrophic factor, inflammation, and behavioral/psychological factors. Regarding efficacy, side effects, and health benefits, aerobic exercise is a potentially beneficial strategy in the preventive treatment of migraine. Further studies are needed to delineate an evidence-based exercise program for migraine treatment.

Entities:  

Keywords:  Aerobic exercise; Exercise; Headache; Migraine; Physical activity

Year:  2021        PMID: 33630184     DOI: 10.1007/s11916-020-00929-w

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  87 in total

Review 1.  Exercise, not to exercise, or how to exercise in patients with chronic pain? Applying science to practice.

Authors:  Liesbeth Daenen; Emma Varkey; Michael Kellmann; Jo Nijs
Journal:  Clin J Pain       Date:  2015-02       Impact factor: 3.442

Review 2.  Migraine: Epidemiology, Burden, and Comorbidity.

Authors:  Rebecca C Burch; Dawn C Buse; Richard B Lipton
Journal:  Neurol Clin       Date:  2019-08-27       Impact factor: 3.806

Review 3.  Migraine prophylaxis: what is new and what we need?

Authors:  P Barbanti; C Aurilia; G Egeo; L Fofi
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 4.  Comorbidity of migraine.

Authors:  Ann I Scher; Marcelo E Bigal; Richard B Lipton
Journal:  Curr Opin Neurol       Date:  2005-06       Impact factor: 5.710

Review 5.  The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.

Authors:  Michael J Marmura; Stephen D Silberstein; Todd J Schwedt
Journal:  Headache       Date:  2015-01       Impact factor: 5.887

Review 6.  Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Winfried Häuser; Petra Klose; Jost Langhorst; Babak Moradi; Mario Steinbach; Marcus Schiltenwolf; Angela Busch
Journal:  Arthritis Res Ther       Date:  2010-05-10       Impact factor: 5.156

Review 7.  The epidemiology, burden, and comorbidities of migraine.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

8.  Rejection and acceptance of possible side effects of migraine prophylactic drugs.

Authors:  Pedro A Kowacs; Elcio J Piovesan; Stewart J Tepper
Journal:  Headache       Date:  2009-04-28       Impact factor: 5.887

9.  Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers.

Authors:  D C Buse; A Manack; D Serrano; C Turkel; R B Lipton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-02-17       Impact factor: 10.154

10.  Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.

Authors:  Richard B Lipton; Sagar Munjal; Dawn C Buse; Aftab Alam; Kristina M Fanning; Michael L Reed; Todd J Schwedt; David W Dodick
Journal:  Headache       Date:  2019-08-13       Impact factor: 5.887

View more
  1 in total

1.  Exercise interventions in migraine patients: a YouTube content analysis study based on grades of recommendation.

Authors:  Álvaro Reina-Varona; Borja Rodríguez de Rivera-Romero; Carlos Donato Cabrera-López; José Fierro-Marrero; Irene Sánchez-Ruiz; Roy La Touche
Journal:  PeerJ       Date:  2022-09-30       Impact factor: 3.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.